Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach.

Hdl Handle:
http://hdl.handle.net/10147/305957
Title:
Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach.
Authors:
McDermott, Shaunagh; O'Neill, Ailbhe C; Skehan, Stephen J
Affiliation:
St Vincent's University Hospital, Elm Park, Dublin 4, Ireland. mcdermottshaunagh@gmail.com
Citation:
Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach., 37 (2):194-200 Clin Imaging
Journal:
Clinical imaging
Issue Date:
2013
URI:
http://hdl.handle.net/10147/305957
DOI:
10.1016/j.clinimag.2012.05.006
PubMed ID:
23465968
Abstract:
In contrast to other common types of malignant tumors, the vast majority of gastroenteropancreatic neuroendocrine tumors are well differentiated and slowly growing with only a minority showing aggressive behavior. It is important to accurately stage patients radiologically so the correct treatment can be implemented and to improve prognosis. In this article, we critically appraise the current literature in an effort to establish the current role of radiologic imaging in the staging of neuroendocrine tumors. We also discuss our protocol for staging neuroendocrine tumors.
Item Type:
Article
Language:
en
MeSH:
Diagnostic Imaging; Evidence-Based Medicine; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis
ISSN:
1873-4499

Full metadata record

DC FieldValue Language
dc.contributor.authorMcDermott, Shaunaghen_GB
dc.contributor.authorO'Neill, Ailbhe Cen_GB
dc.contributor.authorSkehan, Stephen Jen_GB
dc.date.accessioned2013-11-29T15:01:24Z-
dc.date.available2013-11-29T15:01:24Z-
dc.date.issued2013-
dc.identifier.citationStaging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach., 37 (2):194-200 Clin Imagingen_GB
dc.identifier.issn1873-4499-
dc.identifier.pmid23465968-
dc.identifier.doi10.1016/j.clinimag.2012.05.006-
dc.identifier.urihttp://hdl.handle.net/10147/305957-
dc.description.abstractIn contrast to other common types of malignant tumors, the vast majority of gastroenteropancreatic neuroendocrine tumors are well differentiated and slowly growing with only a minority showing aggressive behavior. It is important to accurately stage patients radiologically so the correct treatment can be implemented and to improve prognosis. In this article, we critically appraise the current literature in an effort to establish the current role of radiologic imaging in the staging of neuroendocrine tumors. We also discuss our protocol for staging neuroendocrine tumors.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Clinical imagingen_GB
dc.subject.meshDiagnostic Imaging-
dc.subject.meshEvidence-Based Medicine-
dc.subject.meshGastrointestinal Neoplasms-
dc.subject.meshHumans-
dc.subject.meshNeoplasm Staging-
dc.subject.meshNeuroendocrine Tumors-
dc.subject.meshPancreatic Neoplasms-
dc.subject.meshPrognosis-
dc.titleStaging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach.en_GB
dc.typeArticleen
dc.contributor.departmentSt Vincent's University Hospital, Elm Park, Dublin 4, Ireland. mcdermottshaunagh@gmail.comen_GB
dc.identifier.journalClinical imagingen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.